Please login to the form below
respiratory
This page shows the latest respiratory news and features for those working in and with pharma, biotech and healthcare.
Roche buys GenMark for $1.8bn to bolster diagnostics portfolio
Swiss pharma company will gain respiratory pathogen panels to strengthen its COVID-19 testing capabilities. ... As part of its proposed acquisition of GenMark, Roche will add the company’s respiratory pathogen panels to its arsenal.
Latest news
-
Pfizer/BioNTech vaccine is 94% effective after second dose, major real-world study finds
The early findings come from the SIREN study, which involves a sample of healthcare workers who are undertaking symptom questionnaires, respiratory swabs and serum samples.
-
FDA fast-tracks review of Incyte’s Jakafi for chronic GVHD
In this trial, the number of patients who died or required mechanical ventilation due to respiratory failure or ICU care by day 29 was 12% for Jakafi-treated patients and
-
First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
dose. The early findings come from the SIREN study, which involves a sample of healthcare workers who are undertaking symptom questionnaires, respiratory swabs and serum samples.
-
GSK launches late-stage testing of RSV vaccine candidate in older adults
GlaxoSmithKline (GSK) has launched a phase 3 trial investigating its respiratory syncytial virus (RSV) vaccine candidate in older adults.
-
Verily and Janssen to collaborate on home-based COVID-19 immune response study
Acute respiratory distress syndrome caused by SARS-COV-2 and other viral and bacterial pathogens carries with it a high mortality rate, and more than 2.2 million people will suffer ... Since immune response patterns observed in COVID-19 patients are
More from news
Approximately 28 fully matching, plus 602 partially matching documents found.
Latest Intelligence
-
Virtual congresses: video thrilled the cardio tsar
Its application to major congresses across all medical disciplines – from cancer to cardiovascular, respiratory to rheumatology – will undoubtedly continue.
-
Well-funded life sciences firms are making long-term progress – and their investors are too
Up to that point, the drug was being developed to treat respiratory viral infections in patients with COPD who are at risk of experiencing exacerbations, which can be deadly and typically ... challenge study, in this case respiratory syncytial virus (RSV)
-
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Much of this growth is being driven by the urgent need to innovate in chronic diseases such as cancer, diabetes, mental illness, heart disease and respiratory disease.
-
NICE – but not enough
Figure 2 shows the sales of GSK’s respiratory treatment, Anoro Ellipta, across the various availabilities.
-
Exploring the potential of eosinophils
when starting his research career in Southampton, UK before going on to be Professor of Allergy and Respiratory Medicine at Southampton University. ... GSK has an extraordinary heritage in respiratory research to try to benefit patients with respiratory
More from intelligence
Approximately 1 fully matching, plus 84 partially matching documents found.
Latest appointments
-
VMLY&Rx taps Nichole Davies for global chief strategy officer role
Her experience spans a number of areas, including oncology and immunology, rare disease, respiratory, women’s health, diabetes, nutrition and hospitals.
-
McCann Health North America appoints Jim Joseph as president
Joseph also has expertise in a number of therapeutics areas, including cardiovascular, upper respiratory, HIV, dermatology and more.
-
AstraZeneca taps internal candidate to become UK president
Most recently, he served as senior vice president of the company’s global respiratory and immunology franchise.
-
New hires at Crescendo, Healx and Galecto
Prior to eTheRNA, Lindmark served as global VP of clinical development for the respiratory and inflammation franchises at AstraZeneca. ... In that role, he led the development of Symbicort, a leading respiratory brand.
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Under Bahija’s leadership, MedImmune significantly boosted its pipeline, expanding from 40 to more than 130 molecules in research and development targeting cancer; respiratory, inflammation, and autoimmunity; cardiovascular, renal and metabolic;
More from appointments
Approximately 0 fully matching, plus 50 partially matching documents found.
Latest from PMHub
-
After a busy first quarter, emotive welcomes five new team members
Not only does Dorothy bring with her solid experience in diabetes, CVRM, respiratory and nutrition, she expands emotive’s wide language repertoire to include Mandarin Chinese. .
-
Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics
1 ready in inhaled form (for the long-term maintenance of respiratory function in CF patients). ... therapy for the treatment of airway infections associated with CF, ABPA and other acute and chronic fungal diseases of the respiratory tract.
-
Covid-19 drives change in long-term conditions management
Remote monitoring is key to enabling more people to successfully manage their conditions at home and one area in which it can be successfully deployed is in respiratory diseases. ... In common with many other long-term condition patients, people with
-
Understanding COVID-19 and varying responses across the globe
However, COVID-19 is thought to have come possibly from bats. The symptoms can range from mild to severe, all affecting the respiratory system, from fever and fatigue to complete respiratory ... There are three main ways that respiratory viruses are
-
Covid-19: how is it impacting on the NHS Long-term Plan?
To help manage care during the crisis, NHS England has issued a series of guides outlining how patients with conditions ranging from cardiovascular to diabetes and respiratory conditions should be treated
More from PMHub
Approximately 2 fully matching, plus 28 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Account Management
-
Competitive Salary Offered
-
Principal Medical Writer
-
Varies on experience
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Oxford University to investigate nasal spray delivery of AZ-partnered COVID-19 vaccine
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- Bedrock Group rebrands as Resonant Group
- New restrictions for AZ/Oxford COVID-19 vaccine despite EMA endorsement
- Moderna launches COVID-19 vaccine booster study to address new variants
- WHITE PAPER: Why do men die younger?
- Opdivo improves survival in oesophageal cancer
- Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
- UPDATE: AZ/Oxford University COVID-19 vaccine gets EU approval
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Roche, Regeneron’s COVID-19 antibody cocktail cuts infection risk
PMHub
Purple Agency
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....
Latest intelligence
- WHITE PAPER: Why do men die younger?
- It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
- 3 tips to show patient diversity in your clinical trial materials
- Here are some useful tips to help get your hands on authentically diverse stock photos....
- Virtual congresses: video thrilled the cardio tsar
- Chris Ross explores the key learnings from a year of virtual congresses...
Quick links
Infographics
